BOSTON, MA--(Marketwire - Nov 7, 2012) - Digital Lumens today announced that Vector Aerospace, an industry-leading provider of maintenance, repair and overhaul (MRO) services for fixed wing and rotary ...

Sanofi is playing catch-up in gene therapy, but new CEO Paul Hudson is taking quick steps to close the gap. A reorganization of the R&D unit is intended to pivot the drugmaker toward immuno-oncology ...

(Sharecast News) - Commercial lender Vector Capital updated the market on its loan facilities on Monday, including those provided by Vector Holdings, reporting that it had extended its wholesale ...

A medical school in the U.S. has built a large-scale manufacturing facility to overcome bottlenecks in adeno-associated virus (AAV) production. The AAV large-scale manufacturing facility, which opened ...

Vector Biolabs, a custom design and manufacturing service provider for AAV and adenovirus viral vectors announced the completion of a facility expansion to meet growing demand. The purpose of the ...

PITTSBURGH—Vector Security, a provider of residential and commercial security and automation solutions, announced this week it has entered into a $450 million credit agreement led by PNC Bank, with ...

The European Aeronautic Defence and Space Co. said today that its Eurocopter subsidiary completed the purchase of Vector Aerospace Corp. in a $638 million deal that includes the Canadian company's ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced plans for a new 67,000-square-foot facility in Oceanside, California, dedicated to the development and ...

The company announced plans to expand its viral vector process development facilities in the United States and its cleanroom facilities in the Netherlands for vector-based products. On Oct. 16, 2017, ...

Vector Aerospace has successfully completed its first full engine overhaul on the Pratt & Whitney Canada (P&WC) PT6A-140 turboprop engine at its facility in South Africa. Above: The Vector Aerospace ...

Kite, a Gilead company, announced plans to build a new facility for the development and manufacturing of the starting material for the production of cell therapies, viral vectors. Kite, a Gilead ...

The contract manufacturer Novasep will spend $29 million to build a viral vector facility in Seneffe, Belgium. The facility will house two suites equipped with single-use bioreactors ranging in size ...